Search clinical trials for: GSK1363089

Total 6 results

GlaxoSmithKline

Completed

A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

Solid Tumours

United States
GlaxoSmithKline

Completed

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Carcinoma, Renal Cell

United States
GlaxoSmithKline

Completed

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid Tumors

Solid Tumours
GlaxoSmithKline

Completed

Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck

Neoplasms, Head and Neck

United States
GlaxoSmithKline

Completed

A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors

Solid Tumours
GlaxoSmithKline

Completed

Study of GSK1363089 in Metastatic Gastric Cancer

Neoplasms, Gastrointestinal Tract

United States

3

Subscribe